Replies to post #110 on Catalyst Pharmaceutical Partners (CPRX)

[DonShimoda]

I might give your argument more weight if it weren't for the simple fact that the stock went UP 40% AFTER the director sold his shares. If you're right then we'll see Coelho file a Form 4 this week but I'm not holding my breath.

Thanks for asking but what I own and the price I own it at is my business but suffice it to say that I could care less about whether CPRX goes up or down 25 cents. I've always found trying to time the bottom to be a fools game. In the greater scheme of things whether I buy at a 25mm market cap or a 30mm market cap isn't going to make a bit of difference to me.

Best of luck trying to invest only in biotechs that don't need to raise $. That's a pretty small universe of very pricey stocks, lol.

[DonShimoda]

Check your math. In your analysis you valued the warrant as if it were a "free" share of stock. This was a mistake. The warrant is simply a 5 year option with an assumed $1.30 strike. Using black-scholes, the current value of the warrant is around 30 cents. Since investors received half a warrant for each underlying share, the real value given up is around 15 cents and not the 1.15 your analysis assumed. So, no, I don't think it will trade at 77 cents, but if it does you can be assured I'll be adding to my position.

the real price today(if your bought through the financing) was closer to .77/share